Abstract
The clinical features of COVID-19 are varied, ranging from asymptomatic state to acute respiratory distresssyndrome and multi organ dysfunction. We aim to evaluate renal and liver functions of patients with COVID19. Laboratory results were obtained from 107 patients with laboratory-confirmed COVID-19 who wereadmitted to the only Al-Furat General Hospital in Baghdad, Iraq from March 3 to June 9, 2020 and followedup until recovery. Normal levels of renal functions were presented. Meanwhile elevated levels of alanineaminotransferase (ALT) was observed in 10% and of aspartate aminotransferase (AST) was observed in40% of patients with COVID 19,yet on comparison of the results at entering with at recovery it was observedsignificant differences (p<0.01) of all patients. From these findings we conclude that the virus might beresponsible for systemic inflammation.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
